Wired reports, as have others, that private investment in embryonic stem cell research is picking up. From Robert Lanza of Advanced Cell Technology: "With the passage of Proposition 71 there's been an influx of interest in stem cells. We're in a whole new world. We're flush with cash, and just months ago we were struggling as a private company to even make payroll and to keep the phones on." The article notes that "will soon announce an $8 million investment from private and venture investors, with more on the way" and that "the company has nearly tripled in size." Capital investment is the engine of progress - good to see more of it in a field that will produce cures for age-related disease.